Geritom Med, Inc. – Trademark Portfolio

Entity Type: 03

Geritom Med, Inc. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 9 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 0 trademarks are registered and 9 are pending. The owner is based in Bloomington, MN.

10501 Florida Avenue S.

Bloomington, MN 55438

10 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Geritom Med, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (9 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

42
Computer & Scientific (6 filings)

Scientific and technological services; industrial analysis and research services

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Geritom Med, Inc. have?

Geritom Med, Inc. has 10 U.S. trademarks filed with the USPTO. Of these, 9 pending, 1 abandoned.

What trademark classes does Geritom Med, Inc. file in?

Geritom Med, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 5 (Pharmaceuticals). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What is Geritom Med, Inc.'s trademark registration success rate?

Geritom Med, Inc. has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 9 applications are pending review.